The medical device industry is pressured to aid those stricken by the pandemic, while at the same time working to mitigate increased risks usually associated with hurried manufacturing and quality control procedures.
Medtech companies will need to collaborate more closely with other parties in healthcare, as the aftermath of the coronavirus pandemic will have a comprehensive reach throughout the entire ecosystem. MTI speaks with Johnson & Johnson VP Raymond Fryrear, M.D. on the topic.
Overall activity in deals jumped 11% in North America.
Here’s a hint: EU MDR and recalls were among the hot topics.